Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations.
Karen JordanChristopher G FawsittPaul G CartyBarbara ClyneConor TeljeurPatricia HarringtonMairin RyanPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Published high-quality studies suggest metabolic surgery is a cost-effective or cost-saving intervention. As the prevalence of obesity and obesity-related diseases increases worldwide, significant investment and careful consideration of the resource requirements needed for metabolic surgery programmes will be necessary to ensure that service provision is adequate to meet demand.
Keyphrases
- type diabetes
- minimally invasive
- insulin resistance
- coronary artery bypass
- metabolic syndrome
- weight loss
- high fat diet induced
- weight gain
- surgical site infection
- randomized controlled trial
- healthcare
- mental health
- cardiovascular disease
- risk factors
- percutaneous coronary intervention
- adipose tissue
- palliative care
- atrial fibrillation
- body mass index
- physical activity
- coronary artery disease
- combination therapy